Lehi, Utah – November 10, 2026 – PRESSADVANTAGE –

Waite Vision, a LASIK surgeon located in Lehi, Utah, has published a new educational article examining why prospective patients postpone refractive surgery and what that postponement involves. The practice provides LASIK, PRK, SMILE, EVO ICL, and Refractive Lens Exchange to patients in Lehi, Salt Lake City, Provo, and Utah County. The article, “I’ll Just Wait Until the Technology Gets Better”: Why Perpetual Postponement Is the Worst LASIK Strategy, addresses a decision pattern the practice reports encountering among people who have researched LASIK for years without scheduling a diagnostic evaluation.

The article identifies status quo bias, the tendency to default to inaction because inaction feels safer than change, as a common factor in delayed decisions about laser vision correction. It acknowledges that caution about elective surgery involving the eye is reasonable, and the reasoning behind a decision to wait often sounds prudent on its face. It observes that people who have managed a refractive error for years often normalize the daily friction involved, and waiting for a better future procedure can become a reason to remain in place. The article distinguishes between due diligence, which has a natural endpoint, and indefinite delay, which does not.

On the current state of the technology, the article notes that LASIK has been approved by the U.S. Food and Drug Administration for more than 25 years, and that current procedures use wavefront-guided and topography-guided laser platforms, femtosecond lasers for corneal flap creation, and real-time eye tracking that compensates for small micro-movements during surgery. It explains that the excimer laser reshapes the cornea to address myopia, astigmatism, and farsightedness at the source, rather than compensating for the refractive error in front of the eye as glasses and contact lenses do. Institutional adoption has followed that clinical record. NASA approved LASIK for members of the astronaut corps in September 2007, and the U.S. Army, Navy, and Air Force have performed refractive surgery on service members through the Department of Defense Warfighter Refractive Surgery Program.

The article also addresses the expectation of a single transformational advance in vision correction. It states that medical technology generally advances in measured increments, and that approaches such as gene therapy, stem cell treatment, and next-generation lens replacement remain under research rather than in routine clinical use, and it notes a distinction between approaches available within clinical trials and approaches ready for routine surgical use. It describes a scenario in which a procedure deferred in 2010 was deferred again through 2024, with those years spent managing a refractive error using glasses and contact lenses while the anticipated advance did not arrive.

“Refractive surgery has been advancing in increments rather than in sudden leaps, and that pattern is likely to continue,” said Aaron Waite, MD, fellowship-trained, board-certified ophthalmologist and founder of Waite Vision. “The question for an individual patient is not whether the technology will improve, but whether that patient meets candidacy criteria now, and that question is answered by a diagnostic examination rather than by further reading.” Dr. Waite completed a fellowship in cornea, external disease, and refractive surgery at the University of Colorado School of Medicine and previously served as Director of Cornea, Cataract, and Refractive Surgery at the University of Tennessee Hamilton Eye Institute. He is a clinical faculty member at the University of Utah Moran Eye Center, has published in the Journal of Cataract and Refractive Surgery and the American Journal of Ophthalmology, and received the 2010 ASCRS Foundation Resident Excellence Award.

LASIK and other refractive procedures carry risks, including dry eye, glare, halos, and the possibility of residual refractive error that requires additional correction, and results vary among individual patients. Candidacy requirements differ by procedure and by patient rather than applying uniformly. The criteria described in the article, which include a prescription that has remained stable for at least one year, adequate corneal thickness and corneal health, a minimum age of 18, and the absence of conditions such as severe dry eye syndrome or significant corneal disease, pertain to LASIK and are assessed individually during a clinical examination. The article describes a consultation as a diagnostic evaluation intended to establish whether LASIK, another refractive procedure, or no procedure is appropriate for a given patient.

Waite Vision is located at 3333 N Digital Drive, Suite 300, Lehi, Utah 84043, and driving directions to the practice are available through Google Maps. The practice can be reached at 801-876-6000. For more information about LASIK in Lehi, Utah, the full article is available on the Waite Vision website at waitevision.com, and practice hours, location details, and contact information are listed on the Waite Vision Google Business Profile. Waite Vision will continue to publish patient education material on refractive surgery for patients throughout Utah.

###

For more information about Waite Vision, contact the company here:

Waite Vision
Jen Martin
(801) 876-6000
info@waitevision.com
3333 Digital Dr #300
Lehi, UT 84043

Media gallery

About The Author
PressAdvantage